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Abstract
Objectives—To describe unique features of neurocritical illness that are relevant to provision of 
high-quality palliative care; To discuss key prognostic aids and their limitations for neurocritical 
illnesses; To review challenges and strategies for establishing realistic goals of care for patients in 
the neuro-ICU; To describe elements of best practice concerning symptom management, 
limitation of life support, and organ donation for the neurocritically ill.
Data Sources—A search of Pubmed and MEDLINE was conducted from inception through 
January 2015 for all English-language articles using the term “palliative care,” “supportive care,” 
“end-of-life care,” “withdrawal of life-sustaining therapy,” “limitation of life support,” 
“prognosis,” or “goals of care” together with “neurocritical care,” “neurointensive care,” 
“neurological,” “stroke,” “subarachnoid hemorrhage,” “intracerebral hemorrhage,” or “brain 
injury.”
Data Extraction and Synthesis—We reviewed the existing literature on delivery of palliative 
care in the neurointensive care unit setting, focusing on challenges and strategies for establishing 
realistic and appropriate goals of care, symptom management, organ donation, and other 
considerations related to use and limitation of life-sustaining therapies for neurocritically ill 
patients. Based on review of these articles and the experiences of our interdisciplinary/
interprofessional expert Advisory Board, this report was prepared to guide critical care staff, 
palliative care specialists, and others who practice in this setting.
Conclusions—Most neurocritically ill patients and their families face the sudden onset of 
devastating cognitive and functional changes that challenge clinicians to provide patient-centered 
palliative care within a complex and often uncertain prognostic environment. Application of 
palliative care principles concerning symptom relief, goal setting, and family emotional support, 
will provide clinicians a framework to address decision-making at a time of crisis that enhances 
patient/family autonomy and clinician professionalism.
Keywords
neurocritical care; neuro ICU; intensive care unit; palliative care; end of life care
Introduction
Neurocritical illness, defined as critical illness primarily involving the brain, spinal cord, or 
neuromuscular system [1], is often a sudden, catastrophic event for patients and their 
families. Although advances in neurocritical care continue to improve outcomes, mortality 
rates for common conditions including intracerebral hemorrhage and anoxic brain injury 
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range above 50%, and many patients never regain functional independence (Table 1). 
Patients often experience significant cognitive loss along with deterioration in quality of life.
[2, 3] Even for those who survive without permanent disabilities, recovery from 
neurological injury can be prolonged and accompanied by physical and psychological 
distress for patients as well as practical and emotional burdens for families. For these 
reasons, palliative care, including communication about goals of care in relation to the 
patient's condition, prognosis, and preferences, is an important component of high quality 
care in the neurocritical care environment.
Palliative care focuses on relief of symptoms, effective communication about goals of care, 
alignment of treatment with patient preferences, family support, and planning for transitions.
[4, 5] Whereas hospice or end of life care is for patients approaching death, palliative care is 
appropriate in the context of any serious illness, regardless of stage or prognosis, and is 
optimally provided together with, not in lieu of, disease-directed or life-prolonging 
treatment. Palliative care is an interprofessional specialty, but also an approach for all 
clinicians caring for seriously ill patients who are expected to provide excellent “generalist”-
level palliative care.[6]
In this article, The IPAL-ICU (Improving Palliative Care in the ICU) Project Advisory 
Board brings interdisciplinary and interprofessional expertise together to address challenges 
and strategies regarding prognostication, communication, and decision making for the 
neurocritical care patient and family.
Onset and Trajectory of Neurocritical Illness
The onset of neurocritical illness is usually abrupt and follows a trajectory that is distinct 
from that of other patients with life-threatening illness (Figure 1).[7, 8] Neurocritically ill 
patients often face a sudden and total transformation from good health and independence to 
the prospect of death or serious and permanent disability. Over 70% of patients in the neuro-
ICU have no premorbid symptoms and present with a precipitous loss of physical and 
cognitive function.[9, 10] Therefore, from the onset, clinicians face the challenge of helping 
families cope with the impact of an unexpected and devastating illness, making it more 
difficult to focus on the decision-making process.
Decision-making is further complicated by the unpredictable and extended course of many 
forms of neurocritical illness. Often, patients do not progress to death (by cardiovascular or 
brain-based criteria) after neurological injury, but instead either improve slowly over several 
months or stagnate in a severely disabled state. Most deaths among the neurocritically ill 
occur after limitation of life-sustaining therapies. Nationally, 13.5% -15% of patients in 
neuro-ICUs have life-sustaining therapies withheld or withdrawn, and limitation of such 
therapies precedes up to 61% of all deaths in the neuro-ICU.[9-11] In those who do not die, 
recovery is prolonged. Brain-injured patients make their maximal spontaneous recovery over 
3-6 months, though improvement can continue over the ensuing months with aggressive 
rehabilitation.[12-15] Therefore, neurological changes that would affect decision-making 
often occur well after the ICU and hospital stay, necessitating the use of prognostic scales 
that can assist in early discussions about goals of care.
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Prognosis: Tools and Limitations
For some forms of neurocritical illness, specific clinical and radiographic features are 
predictive of poor neurological outcome across a number of studies (Table 2).[16] However, 
these predictors were derived primarily from observational studies, refer to a variety of time 
frames as outcomes, and have other limitations as outlined below. In general, the loss of 
brainstem reflexes, with radiographic confirmation of destruction of the brainstem or diffuse 
cortical infarction, is incompatible with meaningful functional recovery. Though survival is 
possible, the anticipated quality of life is often deemed unacceptable. In circumstances 
where the prognosis is less certain, it is important for clinicians to know the strengths and 
weaknesses of existing outcome data and prognostic models. Addressing uncertainty is an 
important part of communicating with patients and families to establish realistic goals of 
care.
A variety of prognostic scales offer useful outcome estimates for common neuro-ICU 
conditions (Table 3). The Glasgow Coma Scale [17] was developed for patients with 
traumatic brain injury (TBI). This scale (assessing eye opening, motor response, and verbal 
response, with lower scores reflecting more severe injury) is often used for serial 
abbreviated neurological exams and provides a globally recognized standard in neurological 
assessment. The GCS is a highly reliable predictor of in-hospital mortality, but has limited 
use for predicting long-term functional outcome of survivors. This scale has been applied 
across a wider spectrum of neurological diagnoses, including intracranial hemorrhage.[18] 
The NIH Stroke Scale is one of the most reliable instruments to predict outcome after 
ischemic stroke.[19] In North America, the Hunt-Hess Grade [20] for subarachnoid 
hemorrhage (SAH) is highly correlated with mortality and functional outcome. The 
Intracerebral Hemorrhage (ICH) [18] and FUNC [21] scores are used to predict mortality 
and functional outcomes, respectively, after intracerebral hemorrhage. These scales were 
developed to estimate the most likely outcome, though application on an individual level is 
more complex.
Impact of withdrawing life-sustaining treatment—Most studies describing the 
outcome of patients with severe brain injury have included patients from whom life-
sustaining therapy was withheld or withdrawn. Yet, studies of ICH, SAH and TBI patients 
have found that an early “do not attempt resuscitation” (DNAR or DNR) directive and/or 
withdrawal of life-sustaining treatment as much as doubled the short- and long-term 
mortality, even after adjusting for known predictors of mortality (age, gender, ethnicity, 
Glasgow Coma Scale, ICH volume, intraventricular hemorrhage and infratentorial 
hemorrhage).[22-26] Thus, reliance on existing mortality data for prognostication can give 
rise to a “self-fulfilling prophecy” and perpetuate high mortality rates. Inclusion of patients 
undergoing early limitation of life support can confound the development of new prognostic 
models and hamper clinical trials to develop life-saving interventions for neurocritically ill 
patients. However, it is ethically important to offer families the option of withdrawal of life-
support in keeping with the patient's right to autonomy and right to make an informed 
decision. A possible approach to this conundrum would be to use functional outcomes rather 
than mortality as primary endpoints. The development of new technologies and 
methodologies to predict outcome [27] after neurological injury is essential to improving the 
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design of clinical trials and strengthening the ability of clinicians and families to make 
informed decisions about appropriate goals of care.
Model Characteristics—Models that predict functional outcome and quality of life, 
rather than mortality alone, would be more valuable for both clinicians and families. 
However, existing functional outcome scores (such as the Glasgow Outcome Score [28] or 
the modified Rankin Score [29, 30]) are heavily weighted toward motor ability and do not 
take into account other important outcomes such as cognitive and emotional function and 
quality of life, which are of utmost importance to patients and families.[31, 32] Prediction 
models for quality of life after neurocritical care have not been robustly developed, and 
proxy assessment tools to measure quality of life are scant and not well validated. Many 
studies use dichotomized outcomes, with arbitrary and varying cut-points that may not be 
meaningful for patients and their families. For example, the modified Rankin Scale (mRS) 
[29, 30], which ranges from 0 (no symptoms) to 6 (death), is variably dichotomized as 0-3 
(0=no symptoms, 3=moderate disability requiring some help but able to walk without 
assistance) versus 4-6 (4=moderately severe disability; unable to walk without assistance or 
attend to bodily needs, 6=death), or as 0-1 (0=no symptoms, 1=no significant disability 
despite symptoms) versus 2-6 (2=slight disability but able to carry out own affairs, 6=death). 
Depending on the cut-point used, study results may significantly differ. In addition, trials 
yielding data used to generate prognostic scales often exclude the most severely affected 
patients, for whom little data are then available regarding the impact of treatments. Finally, 
models used for prognostication project what happens to a population on average; they 
cannot predict the outcome of any given individual. Adjustment for case-mix and the use of 
patient or family-reported outcomes in future studies may help improve prognostication, but, 
importantly, such models will always suffer from this inherent limitation.[33, 34] Models 
that predict functional recovery are also limited by the challenges in predicting an individual 
patient's ability to adapt (“response shift”) to a neurologic deficit that the patient has not yet 
experienced, as well as reframing or changing perceptions of quality of life that can occur 
over time.[35, 36]
Models Based on Outdated Practice or Lacking Adequate Validation—Older 
prognostication tools may reflect outdated medical and surgical practices that have evolved 
to offer patients a chance of better neurological recovery.[37] In addition, certain commonly 
used scales have not been validated or rigorously tested in different cohorts.[38]
Practitioner Variability—Survey results suggest that many physicians are both overly 
pessimistic and inaccurate in predicting outcome, particularly within the first 72 hours of 
neurocritical illness.[22, 39] There is also significant variation in physician perception of 
prognosis in case-based scenarios.[40] In addition, early medical and surgical interventions 
in many neurocritical illnesses can substantially alter a patient's clinical course. In 
recognition of these and other factors, the American Heart Association together with the 
American Stroke Association recommends that new DNR orders be deferred and full 
intensive care therapy be administered after ICH at least until the second day of 
hospitalization.[41] An initial trial of full intensive care therapy is also generally appropriate 
for the first 24-72 hours in other types of neurocritical illness, unless the patient has a 
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condition outlined in Table 2 or clearly expressed a different preference through advance 
care planning. A longer period of observation would be appropriate when functional 
recovery is particularly difficult to predict and may continue over weeks to months, as for a 
young patient with traumatic brain injury.
Conversely, some physicians are overly optimistic when discussing prognosis with patients 
and families.[42] The motivation for this optimism may be to maintain hope for recovery, 
and/or avoid emotionally-laden encounters with patients or surrogates. Physicians also 
experience feelings of professional failure that make it difficult to acknowledge that the 
patient faces almost certain death or devastating neurologic impairment.[43] Although hope 
may help patients and surrogates cope with a serious illness, false hope tends to undermine 
the clinician-patient relationship, as well as delay appropriate decision-making.[44]
Public perceptions of recovery
Patients’ and families’ perceptions of neurocritical illness may be influenced by portrayals 
in film and other media that distort the reality of coma, persistent vegetative state, or 
minimally conscious state and tend to exaggerate the recovery prospects. In a review of 30 
movies between 1970 and 2004, only two were found to represent coma realistically and 
60% of coma patients portrayed in films awoke suddenly, even after a prolonged period of 
time, with intact cognition and physical function.[45] Although 15-50% of patients with 
persistent vegetative state regain consciousness over one year, depending on the mechanism 
of injury, the majority of these patients remain moderately-severely disabled and only 7% 
make a functional recovery, defined as mobile, able to communicate, and perform activities 
of daily living.[46, 47] Overall, the life expectancy for patients in persistent vegetative state 
is 2-5 years.[48] Patients with minimally conscious state (defined by intermittent command 
following and/or some ability to interact with their environment) have better long term 
outcomes than those with persistent vegetative state, but still, most remain disabled and 
dependent.[49] “Medically-induced coma” has a very different prognosis for recovery than 
coma resulting from illness or injury, but this distinction is frequently blurred in the media 
and poorly understood by the public.[50] To address potential misperceptions, clinicians 
need to explore the family's understanding of the nature and likely outcomes of the patient's 
condition, focus on the unique clinical circumstances, and endeavor to bring the family's 
perceptions and expectations into closer alignment with medical realities. A public 
education effort addressing the realities of brain injury is needed.
Strategies for establishing goals of care
Integrating the Interdisciplinary, Interprofessional Team—The expertise of a 
variety of clinicians can contribute to optimal care. We recommend that the clinical team 
(including intensivists, neurologists, and neurosurgeons) huddle at each critical discussion 
juncture to present a common message to the family, particularly when presenting prognosis 
and the uncertainty surrounding it. Physical therapists and neuro-rehabilitation specialists 
may be able to provide specific insight into expected long-term disabilities and the recovery 
process. Specialists in palliative care can support both the primary team and the family to 
address difficult decisions and complex symptoms. Ideally, involvement of such specialists 
is not deferred until the patient is imminently dying, since they are most effective when 
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engaged early enough to build a trusting relationship with the family. At the same time, 
basic, generalist-level palliative care, remains the responsibility of the primary team, and 
should be part of daily practice. Both “specialist” and “generalist” models of palliative care 
are effective and a combined approach may represent the optimal model.[51, 52]. Strategies 
for developing such models have been reviewed.[52] ICU staff can be trained to manage 
distressing symptoms and conduct interprofessional/interdisciplinary family meetings, while 
involvement of palliative care specialists can support the primary team, particularly in the 
most challenging situations, and provide continuity of care to the patient and family.[52] 
Bedside ICU nurses can offer significant contributions to communication about appropriate 
and realistic goals of care, especially when physician-nurse communication has been 
optimized.[53] Social work, psychology, ethics services, pastoral care, and case 
management services all have a role to play in helping families.
Timing of Goals of Care Discussions—Effective communication with patients and 
families balances honesty with empathy and hope [54], and proceeds in the context of the 
condition and prognosis as well as the values, goals and preferences of the patient.[55] From 
the time of admission, available prognostic information, and all indicated treatment options 
should be openly discussed, along with a review of prior advance care planning so that the 
patient's wishes are respected. For patients without an advance directive, it is reasonable to 
initiate a time-limited trial of full intensive care therapy, except in extreme circumstances 
(e.g., brain death, poor premorbid function, low probability of successful intervention, and 
factors listed in Table 2). Early intervention may directly alter the patient's prognosis.
Shared, value-based, decision-making—The patient's values, goals and preferences 
provide the touchstone for communication and decision-making. Whether or not the patient 
specifically articulated such wishes, shared decision-making about appropriate goals of care 
entails discussion of the patient's values, including the quality of life that the patient would 
find acceptable. Especially in the context of neurocritical illness, in which patients may 
survive but with significant loss of function and cognition, the scope of discussion between 
clinicians and families must extend beyond a patient's chances for survival, to a fuller 
conversation about achievable goals in relation to the patient's condition, prognosis, and 
values. In these discussions the focus must remain on the values of the patient, rather than 
concerns of the family, or views projected by the clinician. Table 4 outlines an approach that 
facilitates discussion of a patient's values as the basis for decision-making.[55] Putting the 
physician's prognostic estimate of neurological outcome together with the patient's goals and 
values allows for a process of shared decision-making to develop a plan of care (Figure 2).
Communicating Prognosis—When offering an estimated prognosis for neurological 
function, it can be helpful to communicate concrete skills, including activities of daily 
living, which the patient may or may not have a reasonable chance of achieving. For 
example, “the most likely outcome, should full, aggressive life support be applied, is that the 
patient will be completely dependent for all basic activities such as bathing, dressing and 
toileting, and likely require a machine to breathe, a feeding tube, and placement in a nursing 
home.” Or, “the patient will be weak on one side, and unable to walk, but still able to 
communicate and interact meaningfully with loved ones.” It is important to describe not 
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only potential deficits, but also skills that the patient is likely to retain, since certain deficits 
may be acceptable based on the patient's values or prior expressed wishes.
Families often inquire about signs of neurological improvement that may alter prognosis. In 
general, for comatose patients, saccading (quick movements of both eyes in the same 
direction) to voice, tracking, and command-following are signs of improvement. One 
commonly misinterpreted interaction with the comatose patient is the grasp reflex. Since 
primitive reflexes can reemerge in the comatose state, families may believe that the patient 
is squeezing a loved one's hand purposefully. Careful explanation of reflexive movements is 
important for addressing family expectations, with recognition that the family may continue 
to interpret patients’ movements differently.[56]
Addressing Prognostic Limitations—The limitations of current prognostic models 
should not preclude clinicians from sharing an opinion on the patient's potential outcome. 
Communication that acknowledges the uncertainty of outcome predictions can actually build 
trust and is consistent with a shared-decision model of patient-clinician communication and 
with empirical data about patients’ and families’ interest in prognostic information, even if 
there is uncertainty.[57] In addition, communication can acknowledge that prognosis is not 
based on the admission neurological assessment alone, but may be altered by early treatment 
decisions, such as a decision to proceed with surgery. Besides consideration of disease-
specific prognosis, clinicians should account for individual patient factors such as age, 
premorbid functional status, medical comorbidities and admission neurological and 
physiological status that interact to affect prognosis (Figure 2).[58] Some studies suggest 
that the combination of model-based prediction with expert clinician outcome estimates may 
be superior to either approach alone.[59]
Addressing family guilt—Surrogates may feel guilt, doubt, and regret about their 
decisions, especially when the patient was healthy prior to a sudden neurological 
catastrophe. Many surrogates carry these negative emotions for months to years.[60] To 
address and attempt to alleviate such distress, discussions may be framed in terms of the 
obligation to respect the patient's wishes, and the opportunity to help the patient preserve 
dignity when death is inevitable.[61] Intensive care support may only prolong the dying 
process, causing more suffering with the same eventual result.
Presenting Goals of Care Options—Communication about goals of care may be most 
effective when discussions are iterative, with continued discussion that takes account of the 
evolving clinical situation. Clear pathways of care, i.e., full life support including 
tracheotomy and feeding tube placement versus care focused exclusively on comfort (often 
referred to as “comfort measures only”), are the two most typical treatment approaches for 
neurocritically ill patients. Although some physicians may offer partial treatment options 
rather than directly addressing realistic goals of care, this approach can confuse the family, 
and partial treatment plans can lead to the same outcome as a “comfort measures only” 
approach, but with prolongation of the dying process and preventable distress. A time-
limited trial of full intensive care with observation for improvement may be helpful when 
the outcome is unclear.[62] The use of approaches such as “no escalation of treatment,” 
which is another form of partial treatment, is more controversial.[63, 64] Families should be 
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given adequate time to consider and modify goals of care, and to place increasing emphasis 
on palliative care at any stage in the patient's course.
Considerations in Withdrawal of Life-Sustaining Therapies
Symptom Management During Withdrawal of Life Support—The withdrawal of 
life-sustaining therapies should follow a written protocol to ensure attention to all key 
elements, including documentation of the goals of care and the resuscitation status.[65, 66] 
Consideration to family and visitor needs should be given when determining the timing of 
life support withdrawal. Although stroke and other neurocritically ill patients tend to have a 
lower symptom burden than other seriously ill patients,[67] pain, discomfort, and anxiety 
may cause distress even for a brain-injured patient. Patients with spinal cord injury, terminal 
neuromuscular disease, stroke, brain tumor, and other conditions may also suffer from thirst, 
dyspnea, fatigue, sleep deprivation, incontinence, depression, anxiety, delirium and 
emotional lability.[68] Because neuroICU patients are often unable to communicate their 
needs, clinicians must be especially vigilant for signs of discomfort.[69] Tachycardia and 
tachypnea may be the only manifestations of distress, although they are non-specific. 
Treatment of these symptoms in patients with neurocritical illness is similar to that in the 
general critical care population.[69]
Preparation for withdrawal of life-sustaining therapy includes having opioids available at the 
bedside prior to extubation to manage agonal breathing patterns and other signs of air 
hunger or distress. Anticholinergics (e.g., glycopyrrolate) can reduce tracheobronchial 
sections, and gurgling (death rattle) for some patients, although no large-scale, placebo-
controlled study has been conducted to confirm this effect,[70] and death rattle may not be 
correlated with patient respiratory distress.[71] Anxiolytics and other sedatives should be 
immediately available to treat agitation or anxiety. Some ICUs use specific titration goals, 
such as increasing the dose of opioids and/or sedatives to maintain a heart rate less than 100 
beats per minute or respiratory rate less than 20 breaths per minute. Such guidelines offer 
concrete guidance for nursing staff and may help prevent under-treatment of dyspnea and 
agitation.
Medications and interventions that do not offer symptom relief should be discontinued, 
including antibiotics, vasopressors/inotropes, antithrombotics, intravenous hydration, 
artificial feeding and patient monitors. Anti-epileptic medications may be continued since a 
seizure is considered to be an uncomfortable complication.
Long-acting sedatives—It is unnecessary to wait for a washout of long-acting sedative 
medications (e.g., barbiturates) prior to withdrawal of life-sustaining therapy. A prolonged 
delay to withdrawal in this context can be emotionally difficult for families and staff. The 
concept of autonomy supports a patient's ability to limit life support measures at any time, 
even if there is residual medication effect.[72] Withdrawal in the context of long-acting 
sedatives is not causing death, but is “allowing the patient to die” from the underlying 
illness.[73, 74] In addition, the “principle of double effect” supports the use of a therapy that 
is intended to provide symptom relief (such as pentobarbital and other long-acting sedatives 
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for delirium or sleep disruption at end of life),[75-80] even if death is hastened as a 
secondary effect of the therapy.[81]
Organ Donation- Donation after Cardiac Death—Organ donation after cardiac death 
(DCD) and donation following brain death (death by neurological criteria [“DNC”]) are 
important considerations for neurocritically ill patients. The opportunity to save lives 
through organ donation can provide solace to some grieving families.[74, 82] Late or missed 
referrals to the organ procurement organization (OPO) deprive the family and patient of the 
opportunity to donate organs. In the United States, all hospitals are required to notify their 
assigned OPO when specific criteria are met such as loss of brainstem reflexes in a patient 
who may be approaching brain death, or consideration of withdrawal of life-sustaining 
therapies. Early notification is essential to allow time for OPO determination of donor 
suitability and for family decision-making. The decision to withdraw life-sustaining therapy 
should be made independently of discussions regarding organ or tissue donation, and 
withdrawal of life support should occur only after the family has had the opportunity to 
make an informed decision.
Following consent for DCD, extubation occurs in the operating room. The family should be 
offered the opportunity to be present and briefed on the organ recovery process, which 
entails antiseptic measures including prepping and draping prior to extubation. An OPO 
family counselor may be present in the operating room for additional family support. 
Valuable input may also be provided by a palliative care specialist/team [83], a social 
worker, and/or another clinician with appropriate training to support the family. DCD 
involves the use of some therapies (such as intravenous fluids, intravenous heparin, 
hemodynamic monitoring) that support the donation process.[74] To set appropriate 
expectations, the family should be informed that not all patients are suitable donors. If 
cardiopulmonary death does not occur after extubation (generally within an hour) and the 
OPO decides that the patient is no longer a suitable donor, the patient will be returned to the 
ICU or transition to a palliative care unit or other hospital bed for end-of-life care.[74]
Organ Donation: Death by Neurological Criteria—When brain death is expected and 
imminent, the use of aggressive therapies (such as osmotic therapy) may be futile, and lead 
to complications that can compromise organ donation. It is then reasonable to transition 
from “brain protective” strategies of care to “organ protective” strategies. While this 
approach still involves intensive medical management (e.g. treatment of hypotension, 
diabetes insipidus), it allows time for families to come to terms with the concept of brain 
death, and preserves organ homeostasis for possible donation.
Communicating the concept of death by neurologic criteria presents unique challenges as 
this concept is not accepted in certain cultures or religions.[84] Concrete communication, 
such as “brain death means the patient is declared dead,” is essential to avoid 
misunderstanding. In circumstances in which brain death is not accepted by the family, it is 
reasonable to continue mechanical ventilation for a limited time while supporting the family. 
Eliminating blood draws, electrolyte correction and vasopressor use and allowing the patient 
to progress to cardiopulmonary death may be necessary. When the patient/family has 
consented to donation, medical management may involve invasive diagnostic procedures to 
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investigate donor suitability, and therapies aimed at restoring perfusion, such as hormonal 
replacement, and vasopressor support.[82]. Families should be counseled as to these 
possibilities by the OPO and supported throughout the donation process.
Time to death after palliative extubation—A common question raised by family 
members is, when will death occur following extubation? It is important to describe to the 
family what is likely to happen over the minutes, hours or days following extubation. For 
example: “the patient may not be awake, and may make sounds similar to snoring. We 
expect that the patient will drift into a deeper coma and not respond over the next few hours/
days. Eventually the breaths will get further apart until they stop and death comes 
peacefully”. Expected timing of death is relevant in the context of DCD because cessation of 
cardiopulmonary activity within 60 minutes of extubation is a requirement for DCD in most 
states. In a multicenter study of comatose patients with irreversible brain injury undergoing 
palliative extubation, 46% died within 60 minutes. Major predictors of death within 60 
minutes included: absent corneal reflex, absent cough, extensor or absent motor response 
and oxygenation index >3.0 (where oxygenation index= [FiO2 × mean airway pressure in 
cmH2O/PaO2 in torr] × 100).[85] Table 5 shows the DCD-N scoring system to predict the 
likelihood of cardiopulmonary arrest after withdrawal of life support. Other authors have 
produced similar results using equivalent models.[86] ICU specialist opinion regarding the 
probability of death within 60 minutes after withdrawal of life-sustaining therapy has been 
found to be very accurate along with variables such as pH, Glasgow Coma Score, 
spontaneous respiratory rate, PEEP level and systolic blood pressure.[87] Withdrawal of life 
sustaining therapies does not necessarily lead to imminent death. In studies based on the 
Nationwide Inpatient Sample, nearly 40% of patients with ischemic stroke who received 
thrombolysis and nearly 20% of patients with subarachnoid hemorrhage who underwent 
withdrawal of life support survived to hospital discharge. The discharge destination may be 
a long-term care facility or hospice. Additionally, length of stay and mean hospital costs 
were lower in patients who underwent withdrawal.[88, 89]
Conclusions
Neurocritically ill patients and their families have needs that require integration of palliative 
care principles, practices, and services. Attention to the trajectory of neurocritical illness, 
utility and limitations of neuro-prognostic tools, and the public perceptions of coma and 
survival, can help inform effective communication and decision making. A shared, value-
based decision making model for establishing goals of care, and special consideration of 
symptom management and family support during withdrawal of life-sustaining therapy can 
help ensure the delivery of high-quality palliative care to neurocritically ill patients.
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Figure 1. Distinctive Trajectories of Neurocritical Illness
This figure demonstrates trajectories for patients without limitation of life supporting 
therapies. Onset of neurocritical illness is often sudden, with precipitous decline from a 
normal baseline. However, most neurocritically ill patients do not progress to cardiovascular 
death or brain death, but survive with disability.
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Figure 2. Shared Decision Making in Goals of Care Discussions
Both physicians and the patient/surrogate contribute to goals of care discussions. The 
physician should consider how individual patient factors and published prognostic scales 
contribute to the patient's overall prognosis. The patient/surrogate should contemplate the 
patient's advance directive and value system to determine if the best estimated prognosis is 
aligned with the patient's perception of an acceptable quality of life. Based on this balance, a 
shared-decision for appropriate goals of care can be reached.
GCS=Glasgow Coma Score[17]; FOUR Score[90]; Marshall Head Injury Score[91]; 
IMPACT score[92]; CRASH score [93]; ICH=intracerebral hemorrhage; ICH Score[18]; 
FUNC Score[21]; SAH=subarachnoid hemorrhage; Hunt Hess grade[20]; WFNS=World 
Federation of Neurosurgeons Score[94]; HAIR score[95]; ASIA= American Spinal Injury 
Association Scale[96]
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Table 1
Common Adult Neuro ICU Diagnoses and Outcomes
Condition Incidence in U.S. 
(annual)
Mortality Rates (%) Functional Independence at 
3-12 months (%)
In-Hospital 30-Day
Traumatic Brain Injury 2,500,000 [97] 7.5% [98] 21% [99] 25-32%* [100-102]
Ischemic Stroke 795,000 [97] 4.3-70% [98, 103] 16-23%[104, 105] 50% [106-108]
Anoxic Brain Injury 424,000 out-of-hospital 
cardiac arrests [109] 52-90%
^
 [98, 110] 25-40%** [111, 112] 48-55%** [111, 112]
Status Epilepticus^^ 200,000 [113] 14-50% [114, 115] 19-65% [116-118] 42% [119]
Intracerebral Hemorrhage 63,000 [120] 30% [98] 34-50% [120-123] 12-39% [123]
Subarachnoid Hemorrhage 25,000 [124] 20-26% [98, 124-127] 45% [98, 124-127] 16-55% [128, 129]
*Among patients with severe traumatic brain injury
^Overall 90% mortality including those who do not survive to hospital admission [109]
**Among patients who underwent targeted temperature management. Mortality rates are higher and functional outcome worse in patients with 
PEA/asystole arrest compared to Vfib/Vtach arrest.
^^
Patients with refractory status epilepticus (continued seizures after two anti-epileptic drugs have been administered) have higher mortality rates 
and worse functional outcomes.
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Table 2
Conditions that are Predictive of Poor Neurological Outcome [16]
Neurological Insult Features Predictive of Poor 
Prognosis
Time frame of 
outcome 
measurement
Level of Evidence
Hemispheric Ischemic Stroke* Coma with loss of pontomesencephalic brainstem reflexes [130]
Midline shift of the pineal gland >4 
mm within 48 hours of onset [131]
Age >60 years [103, 132]
14 days-6 months Prospective, observational and 
randomized controlled trials
Cerebellar Ischemic Stroke Coma after decompressive 
neurosurgery[133]
3 months Prospective, observational
Lobar Intracerebral Hemorrhage Coma with extensor posturing and 
absent pontomesencephalic brainstem 
reflexes [134-137]
Coma with midline septum pellucidum 
shift >6 mm within 48 hours of onset 
[136]
1-15 months Prospective and retrospective, 
observational
Deep Basal Ganglion Intracerebral 
Hemorrhage
Coma with hydrocephalus and bleed 
volume > 60 mL [135, 138-142]
1-3 months Prospective and retrospective, 
observational
Pontine Hemorrhage Coma with hyperthermia and 
tachycardia
Coma with hemorrhage extension into 
the midbrain or thalamus and acute 
hydrocephalus[143, 144]
3-12 months Retrospective, observational
Cerebellar Hemorrhage Absent oculocephalic reflexes with 
hydrocephalus
Absent corneal reflexes [145-147]
3 months Retrospective, observational
Aneurysmal Subarachnoid Hemorrhage Persistent deep coma or Hunt Hess 
grade 5 after attempts to lower ICP 
[129]
12 months Prospective, observational
*
The risk of poor outcome in patients ≤60 years old with large hemispheric stroke is attenuated by decompressive hemicraniectomy. Mortality is 
reduced from 71% to 22% with hemicraniectomy versus medical management (P<0.0001) and the chances of moderate disability (able to walk 
without assistance or better) at 12 months was 43% with hemicraniectomy versus 21% without (P=0.014).[103]
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Table 3
Selected Prognostic Scales Commonly Used in Neurocritical Illness
Condition Prognostic Scale Scoring Outcome Measure(s) Pros and Cons
Traumatic Brain Injury Glasgow Coma Scale[17] 3 (worst)-15 (best) Mortality, functional outcome Widely used and 
simple, but the 
verbal score 
cannot be 
assessed in 
intubated 
patients; and 
brainstem 
reflexes and 
breathing 
patterns are not 
assessed as part 
of the GCS.
FOUR Score[90]
(Full Outline of 
Unresponsiveness)
0 (worst)- 16 
(best)
In-hospital mortality Has good intra- 
and inter-rater 
reliability and 
distinguishes 
among patients 
with the lowest 
GCS scores. Not 
widely used, and 
predicts only 
mortality, not 
functional 
outcome.
Marshall Classification of Head 
Injury on Head Computed 
tomography[91]
I-VI Intracranial Pressure, 
functional outcome
Widely used and 
has been found 
to predict 
increased 
intracranial 
pressure and 
outcome, but 
focuses primarily 
on CT findings 
and does not 
incorporate exam 
or other 
prognostic 
factors.
Subarachnoid Hemorrhage Hunt-Hess Grade[20] I (best)-V (worst) Mortality, functional outcome Commonly used 
in the U.S., the 
Hunt-Hess grade 
is one of the 
strongest 
predictors of 
outcome after 
subarachnoid 
hemorrhage. It 
does not 
distinguish well 
between 
moderately 
injured grade 3 
patients.
World Federation of 
Neurological Surgeons Scale[94]
1 (best)-5 (worst) Mortality, functional outcome Commonly used 
in Canada and 
Europe, WFNS 
combines the 
GCS score with 
the presence or 
absence of a 
major 
neurological 
deficit. It is 
similar to Hunt-
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Condition Prognostic Scale Scoring Outcome Measure(s) Pros and Cons
Hess scale in 
predicting 
outcome.[148] 
Does not 
distinguish 
outcome well 
among grade III 
patients and there 
is variable 
application of 
what constitutes 
a “major 
neurological 
deficit”.
Intracerebral Hemorrhage ICH Score[18] 0 (best)- 6 (worst) Mortality Widely used and 
simple scoring 
system. Focuses 
on mortality only 
and confounded 
by withdrawal. 
Not validated in 
a separate cohort.
FUNC Score[21] 0 (worst)-11 (best) Functional Outcome Incorporates 
premorbid 
cognitive 
function and 
strongly predicts 
long term 
functional 
outcome. In 
multiple cohorts, 
no patient with a 
FUNC score ≤4 
achieved 
functional 
independence, 
while >80% of 
patients with a 
FUNC score of 
11 were 
functionally 
independent at 3-
months. Not 
widely used.
Anoxic Brain Injury AAN prognostic guideline[149]* Poor outcome predicted by:
Myoclonus status 
epilepticus (24 
hours)
Absent SSEP N20 
bilaterally (24-72 
hours)
NSE>33 μg/L 
(24-72 hours)
Exam with absent 
pupil or corneal 
responses; 
extensor or no 
motor response 
(72 hours)
Mortality, functional outcome Provides a time 
based guideline 
for 
prognostication 
with low false 
positive rates at 
each step. Does 
not account for 
the improved 
outcomes with 
hypothermia/
induced 
normothermia. 
Guidelines are 
nearly a decade 
old.[149]
Spinal Cord Injury American Spinal Injury 
Association Scale (ASIA)[96]
A (worst)- E (best) Motor and Sensory Function The ASIA scale 
was not 
originally 
developed as a 
prognostic scale, 
but does 
correlate with 
functional 
outcome. [96]
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ICH=intracerebral hemorrhage; AAN=American Academy of Neurology; SSEP=median somatosensory evoked potentials; NSE=neuronal specific 
enolase
*Applies to patients who have not undergone therapeutic hypothermia/induced normothermia.
Crit Care Med. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Frontera et al. Page 24
Table 4
Steps in Discussing Goals of Care [54, 150]
Step 1 Introduce After ensuring a quiet setting where all participants can sit down, introduce the members of the 
clinical team and their roles. Ask family to introduce themselves and their relationship to the 
patient.
Step 2 Empathize Express empathy and acknowledge that this is a difficult time and a challenging conversation. If 
the family is too emotionally overwhelmed to absorb and use information, continue responding 
empathically to the emotion before presenting information and decisions.
Step 3 Inquire, Inform, Process 
Emotional Reactions
Inquire into the family's current understanding of the patient's condition. Clarify any gaps in 
understanding and update the family. Use of brain images may be useful for receptive families. 
Use of lay-person terminology is essential (e.g. “bleeding in the brain”, “dead brain tissue”). 
Allow families time to absorb information and ask questions.
Step 4 Understand the patient's 
values
Review advance care planning discussions and written advance directives, if available, with the 
family, and seek out information about patient and family values that can guide decision-
making.
Step 5 Present Prognosis Present the medical team's assessment of the patient's most likely prognosis in terms of future 
cognitive and functional outcome, acknowledging limitations and uncertainty in prognostication. 
Acknowledge the resulting emotional reactions to this information.
Step 6 Present Broad Care Options Offer possible pathways of care that are clearly delineated. In the right context, care focused 
entirely on comfort should be presented as an alternative to continuation of intensive care 
therapies. This approach may become more acceptable over a series of iterative discussions.
Step 7 Family Decision-Making Given the clinician's best estimate of the patient's long-term cognitive/functional outcome, and 
understanding the patient's values, ask the family to reflect on how the patient, if able, would 
decide in the present circumstances. If the family is receptive, the clinician can offer a 
professional recommendation based on best medical evidence and experience.
Step 8 Match Care Goals to Medical 
Plan
Adjust the care plan to match goals including review of current interventions, medications, and 
CPR/DNR status. Ask about specific goals of importance, such as living until an upcoming life 
event, or returning to home rather than a facility.
Step 9 Reflection and Questions Ask the family to summarize their understanding of the conversation. Reflect back what you 
hear the family saying and summarize. Allow time for questions and offer the family time to 
discuss and consider the options.
Step 10 Follow-up and Document Make yourself available for follow-up conversations and questions. Document the results of the 
meeting in the medical record. Discuss plans with team members not present for the meeting.
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Table 5
Prediction of Cardio-pulmonary Arrest After Withdrawal of Life Sustaining Therapy (DCD-N Score).[85]
Component Score
Cough
    Present 0
    Absent 2
Corneal Reflex
    Present 0
    Absent 1
Motor response
    Flexor or better 0
    Extensor or absent 1
Oxygenation Index
    ≤3.0 0
    >3.0 1
Total Score Death within 60 minutes
0 5%
1 27%
2 29%
3 52%
4 80%
5 89%
A score of ≥3 was associated with a 74% probability of death within 60 minutes, while a score of 0-2 was associated with a 77% probability of 
survival beyond 60 minutes.
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